Pier Capital, LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$4,888,683
-38.6%
732,936
-16.6%
0.79%
-31.1%
Q2 2023$7,965,271
+27.0%
879,169
+1.9%
1.14%
+20.2%
Q1 2023$6,272,091862,7360.95%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders